Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Reporter Genes02:11

Reporter Genes

12.9K
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
12.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic regeneration medicines for muscular dystrophy: progress and challenges in pro-regenerative drug development.

Cell regeneration (London, England)·2026
Same author

DMD-Null mice exhibit severe muscle weakness, impaired regeneration, and deficient satellite cell function.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Dystrophin-gene mutation location influences severity of electroretinogram defects in mouse models of Duchenne muscular dystrophy.

BMC medicine·2026
Same author

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models.

International journal of molecular sciences·2026
Same author

A Novel Dysferlin-Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Prostaglandin E2 receptor EP2 is indispensable for maintenance of skeletal muscle stem cells.

Stem cells (Dayton, Ohio)·2026

Related Experiment Video

Updated: Jan 16, 2026

In Vivo Monitoring of Circadian Clock Gene Expression in the Mouse Suprachiasmatic Nucleus Using Fluorescence Reporters
07:44

In Vivo Monitoring of Circadian Clock Gene Expression in the Mouse Suprachiasmatic Nucleus Using Fluorescence Reporters

Published on: July 4, 2018

8.8K

Splice Modulation Studies Using Reporter Mice.

Katsura Minegishi1, Tsukasa Tominari1, Yoshitsugu Aoki2

  • 1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Methods in Molecular Biology (Clifton, N.J.)
|October 1, 2025
PubMed
Summary
This summary is machine-generated.

Antisense oligonucleotides (ASOs) offer exon-skipping therapy for Duchenne muscular dystrophy (DMD). A novel reporter mouse model enables noninvasive, high-throughput evaluation of ASO efficacy for DMD treatment.

Keywords:
Duchenne muscular dystrophyExon skippingFluorescenceIn vivo imaging system (IVIS)LuciferaseReporter mouse

More Related Videos

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

15.0K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.2K

Related Experiment Videos

Last Updated: Jan 16, 2026

In Vivo Monitoring of Circadian Clock Gene Expression in the Mouse Suprachiasmatic Nucleus Using Fluorescence Reporters
07:44

In Vivo Monitoring of Circadian Clock Gene Expression in the Mouse Suprachiasmatic Nucleus Using Fluorescence Reporters

Published on: July 4, 2018

8.8K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

15.0K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.2K

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration.
  • Exon-skipping therapy using antisense oligonucleotides (ASOs) aims to restore dystrophin protein production by correcting the DMD gene's reading frame.
  • Current methods for evaluating ASO efficacy, such as RT-PCR and immunoblotting on biopsied tissues, are labor-intensive and low-throughput.

Purpose of the Study:

  • To develop a novel, high-throughput, and noninvasive method for evaluating the efficacy of exon-skipping ASOs in vivo.
  • To demonstrate the utility of reporter mice for monitoring ASO-induced exon skipping and subsequent protein expression.

Main Methods:

  • Development of reporter mice engineered to express fluorescent proteins upon successful exon skipping.
  • Administration of antisense oligonucleotides (ASOs) designed to induce exon skipping in the dystrophin gene.
  • Noninvasive monitoring of fluorescent protein expression in reporter mice to assess therapeutic efficacy.

Main Results:

  • Exon skipping induced by ASOs resulted in the expression of fluorescent proteins in reporter mice.
  • The reporter system allowed for real-time, noninvasive assessment of ASO-mediated exon skipping.
  • This in vivo approach provides a high-throughput platform for evaluating next-generation ASO therapies.

Conclusions:

  • Reporter mice offer a powerful tool for the high-throughput, noninvasive evaluation of exon-skipping ASO efficacy for Duchenne muscular dystrophy.
  • This novel method streamlines the assessment of ASO-based therapeutic strategies, accelerating drug development.
  • The in vivo reporter system facilitates efficient screening of ASO sequences and modifications for optimal exon-skipping induction.